Regional and temporal changes in HIV-related mortality in British Columbia, 1987-2006

Canadian Journal of Public Health

Volumn 101, Issue 5, 2010, Pages 415-419

  Lima, Viviane D ^a,b   Lepik, Katherine J ^a,b   Zhang, Wendy ^a   Muldoon, Katherine A ^a   Hogg, Robert S ^a,c   Montaner, Julio S G ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

British Columbia; Canada; Death rate; HIV; Mortality; Mortality decline

Indexed keywords

ARTICLE; CANADA; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; RESIDENTIAL CARE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRITISH COLUMBIA; CATCHMENT AREA (HEALTH); HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS;

EID: 79952233018     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404864     Document Type: Article

References (20)

1. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997;315(7117):1194-99.
2. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279(23):1874-75.
3. Mocroft A, Youle M, Morcinek J, Sabin CA, Gazzard B, Johnson MA, et al. Survival after diagnosis of AIDS: A prospective observational study of 2625 patients. BMJ 1997;314(7078):409-13.
4. ART-CC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies (Antiretroviral Therapy Cohort Collaboration). Lancet 2008;372(9635):293-99.
5. CASCADE Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 2000;355(9210):1158-59.
6. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 2007;21(6):685-92.
7. ART-LINC. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 2006;367(9513):817-24.
8. Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in Sub-Saharan Africa: Comparison with HIV-unrelated mortality. PLoS Medicine 2009;6(4):e1000066.
9. Hogg RS, Schechter MT, Montaner JS, Goldstone I, Craib K, O'Shaughnessy MV. Impact of HIV infection and AIDS on death rates in British Columbia and Canada. CMAJ 1994;150(5):711-17.
10. Hogg RS, Heath KV, Strathdee SA, Montaner JS, O'Shaughnessy MV, Schechter MT. HIV/AIDS mortality in Canada: Evidence of gender, regional and local area differentials. AIDS 1996;10(8):889-94.
11. Schanzer DL. Trends in HIV/AIDS mortality in Canada, 1987-1998. Can J Public Health 2003;94(2):135-39.
12. British Columbia Ministry of Finance and Corporate Relations. BC STATS Population Estimates and Projections (P.E.O.P.L.E. 32). Victoria, BC, 2007.
13. British Columbia Ministry of Health Services. British Columbia Health Authorities. Available at: http://www.health.gov.bc.ca/socsec (Accessed December 15, 2008).
14. Druyts E, Rachlis BS, Lima VD, Harvard SS, Zhang W, Brandson EK, et al. Mortality is influenced by locality in a major HIV/AIDS epidemic. HIV Medicine 2009;10(5):274-81.
15. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997;11(8):F59-65.
16. Wood E, Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy 2006;17:55-60.
17. Kim H, Feuer E, Midthune D. Permutation tests for joinpoint regression with applications to cancer rates. Statistics Med 2000;19(3):335-51.
18. National Cancer Institute, Statistical Research and Applications Branch. Available at: http://srab.cancer.gov/joinpoint/ (Accessed November 25, 2008).
19. Ferreros I, Lumbreras B, Hurtado I, Pérez-Hoyos S, Hernández-Aguado I. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users. Addiction 2008;103:651-59.
20. Rekart M, Ogilvie G, Gilbert M, Knowles L, Spencer D, Taylor D, et al. STI prevention and control 2007 annual report. Vancouver, BC: BC Centre for Disease Control, 2007.